Long Acting Injectable Medications Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (First Generation, and Second Generation); End Use (Schizophrenia, Contraception, HIV, and Others), and Geography
Report Code: TIPRE00023213 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET OVERVIEW
Long-acting injectables (LAIs) are unique medicines used in psychiatric pharmacies to help improve patient outcomes. They offer several benefits compared to oral therapy, including confirmed patient adherence, consistent drug delivery, predictable bioavailability, and prevention of antipsychotic overdoses. Its origins in indications such as schizophrenia and contraception, also HIV treatment and prevention.
MARKET SCOPE
The "Global Long-Acting Injectable Medications Market Analysis to 2028" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Long-acting injectable medications market with detailed market segmentation by type, end use, and geography. The report provides key statistics on the market status of the leading Long-acting injectable medications market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
MARKET DYNAMICS
Drivers
Restraints
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Long-acting injectable medications market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Long-acting injectable medications market in these regions.
IMPACT OF COVID-19 ON LONG-ACTING INJECTABLE MEDICATIONS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
The report covers key developments in the Long-acting injectable medications market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Long-acting injectable medications market are anticipated to lucrative growth opportunities in the future with the rising demand for Long-acting injectable medications in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Long-acting injectable medications market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
The Insight Partner's dediLong-acting injectable medicationsed research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Long-acting injectables (LAIs) are unique medicines used in psychiatric pharmacies to help improve patient outcomes. They offer several benefits compared to oral therapy, including confirmed patient adherence, consistent drug delivery, predictable bioavailability, and prevention of antipsychotic overdoses. Its origins in indications such as schizophrenia and contraception, also HIV treatment and prevention.
MARKET SCOPE
The "Global Long-Acting Injectable Medications Market Analysis to 2028" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Long-acting injectable medications market with detailed market segmentation by type, end use, and geography. The report provides key statistics on the market status of the leading Long-acting injectable medications market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on type, the global Long-acting injectable medications market is segmented into first generation, second generation.
- On the basis of end use, the market is segmented into schizophrenia, contraception, hiv, others.
MARKET DYNAMICS
Drivers
- Provides significant clinical advantages like patient compliance, reduced hospitalization.
- Increased use in schizophrenia.
- Favorable reimbursement policies.
Restraints
- The side effects associated with long-acting injectable medications is the major restraining factor for this market.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Long-acting injectable medications market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Long-acting injectable medications market in these regions.
IMPACT OF COVID-19 ON LONG-ACTING INJECTABLE MEDICATIONS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
The report covers key developments in the Long-acting injectable medications market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Long-acting injectable medications market are anticipated to lucrative growth opportunities in the future with the rising demand for Long-acting injectable medications in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Long-acting injectable medications market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Eli Lilly
- Alkermes
- Johnson and Johnson
- Zogenix
- DURECT
- Mapi Pharma
- GSK
- MedinCell
- Oakwood Labs
- Nanomi
The Insight Partner's dediLong-acting injectable medicationsed research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
The List of Companies
1. Eli Lilly
2. Alkermes
3. Johnson and Johnson
4. Zogenix
5. DURECT
6. Mapi Pharma
7. GSK
8. MedinCell
9. Oakwood Labs
10. Nanomi
11. Pharmathen
12. Kashiv BioSciences
1. Eli Lilly
2. Alkermes
3. Johnson and Johnson
4. Zogenix
5. DURECT
6. Mapi Pharma
7. GSK
8. MedinCell
9. Oakwood Labs
10. Nanomi
11. Pharmathen
12. Kashiv BioSciences
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount